Titre : | Treatment outcomes for women with substance use disorders: A critical review of the literature (2010-2016) (2017) |
Auteurs : | D. E. SUGARMAN ; M. E. REILLY ; S. F. GREENFIELD |
Type de document : | Article : Périodique |
Dans : | Current Addiction Reports (Vol.4, n°4, December 2017) |
Article en page(s) : | 482-502 |
Langues: | Anglais |
Discipline : | TRA (Traitement et prise en charge / Treatment and care) |
Mots-clés : |
Thésaurus mots-clés SEXE FEMININ ; TRAITEMENT ; DIFFERENCE DE GENRE ; THERAPIE COMPORTEMENTALE ; PHARMACOTHERAPIE ; PRODUIT ILLICITE ; ALCOOL ; GROSSESSE ; JUSTICE ; EFFICACITE ; COMPARAISON |
Résumé : |
Purpose of Review: This review critically examines recent literature (2010–2016) on substance use outcomes in women-only treatment studies and gender differences in treatment outcomes in mixed-gender studies. We then focus on outcomes in three areas salient to women with substance use disorders (SUDs): treatment of comorbid post-traumatic stress disorder (PTSD), pregnancy and parenting interventions, and treatment for women in the criminal justice system.
Recent Findings: Favorable results were found for behavioral treatments for women including couples therapy and gender-responsive group therapy. When gender differences were observed in mixed-gender behavioral treatment, outcomes were more favorable in women than in men. However, when gender differences were observed in pharmacotherapy trial results, outcomes were worse for women. With regard to the three subgroups that we reviewed, most recent research on co-occurring PTSD and SUD has been secondary analysis studies which suggest that factors such as group attendance and co-occurring psychiatric disorders influence substance use outcomes. In contrast to the other two subgroups examined, behavioral treatments for pregnant women did not show superior outcomes when compared to control groups. However, buprenorphine was found to be safe and effective for use with pregnant women with an opioid use disorder. Finally, studies of treatment outcomes for women in the criminal justice system found preliminary evidence of efficacy for several behavioral treatments. Summary: Consistent with findings of previous reviews, gender alone did not necessarily predict treatment response; rather, interaction of gender and other factors affected outcomes. Evidence showing worse outcomes for women in pharmacotherapy trials, with the exception of buprenorphine with pregnant women, further reinforces the need for research to evaluate differential treatment outcomes for men and women. |
Domaine : | Alcool / Alcohol ; Drogues illicites / Illicit drugs |
Sous-type de document : | Revue de la littérature / Literature review |
Refs biblio. : | 77 |
Affiliation : | Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, USA |
Accueil